Try our beta test site
Trial record 2 of 237836 for:    ALL

It is a Prospective Study Aiming to Identify Incidence and Prevalence of Cardiovascular Diseases, Changes in Physical Activity, Dietary Habits and Anxiety Depression Levels Through a Period of Time in the Naval Personnel (PrOspeCtive HEllenic NAval PersoNnel StUdy in CardiovaScular Diseases) (OCEANUS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Naval Hospital, Athens
Sponsor:
Information provided by (Responsible Party):
MASTROKOSTOPOULOS ANTONIOS, Naval Hospital, Athens
ClinicalTrials.gov Identifier:
NCT03065413
First received: February 22, 2017
Last updated: NA
Last verified: February 2017
History: No changes posted
  Purpose

Prospective study. Starting from 2014 all newly appointed 1st year cadets in Naval Academies will be enrolled until the class of 2025.

Physical examination, food frequency questionnaire, physical activity questionnaire, anxiety/depression questionnaire, medical history will be filled out at first interview.

Specific blood tests will be performed. Every participant will be interviewed every three years and will complete the same questionnaires.

Follow up period is determined ten years after last class enrollment


Condition
Cardiovascular Diseases
Risk Factor, Cardiovascular

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Prospective
Official Title: The PrOspeCtive HEllenic NAval PersoNnel StUdy in CardiovaScular Diseases (OCEANUS Study)

Resource links provided by NLM:


Further study details as provided by Naval Hospital, Athens:

Primary Outcome Measures:
  • Incidence / prevalence of CVD [ Time Frame: 20 years ]

Estimated Enrollment: 3000
Actual Study Start Date: October 2014
Estimated Study Completion Date: December 2035
Estimated Primary Completion Date: December 2025 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy individuals
Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Non signed consent form
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03065413

Contacts
Contact: Antonios Mastrokostopoulos, MD MSc 00302107261000 amastrokostopoulos@yahoo.com
Contact: Georgios Katsimagklis, MD 00302107261629 gvkats@yahoo.gr

Locations
Greece
Athens Naval Hospital Recruiting
Athens, Greece, 11527
Contact: Antonios Mastrokostopoulos, MD MSc    00302107261000    amastrokostopoulos@yahoo.com   
Contact: Georgios Katsimagklis, MD    00302107261629    gvkats@yahoo.gr   
Sponsors and Collaborators
Naval Hospital, Athens
Investigators
Principal Investigator: Aikaterini Roumpi, MD MSc Athens Naval Hospital
  More Information

Responsible Party: MASTROKOSTOPOULOS ANTONIOS, Consultant Cardiologist, Naval Hospital, Athens
ClinicalTrials.gov Identifier: NCT03065413     History of Changes
Other Study ID Numbers: F.700/28/165531/S.2743 
Study First Received: February 22, 2017
Last Updated: February 22, 2017
Individual Participant Data  
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on February 27, 2017